Method for virus clearance

US11052165B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11052165-B2
Application numberUS-201715718831-A
CountryUS
Kind codeB2
Filing dateSep 28, 2017
Priority dateApr 20, 2015
Publication dateJul 6, 2021
Grant dateJul 6, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention discloses a method for virus clearance of a cell culture medium, comprising the steps of: i) providing a bulk medium portion, comprising amino acids and glucose, and a first additive portion, comprising vitamins in aqueous solution; ii) subjecting the bulk medium portion to a high temperature short time treatment (HTST); iii) passing the first additive portion through a virus retentive filter or an ultrafilter; and iv) after steps ii) and iii), mixing the bulk medium portion with the first additive portion to obtain a cell culture medium.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for virus clearance of a cell culture medium, comprising the steps of: i) providing a bulk medium portion, comprising amino acids and glucose; ii) providing a first additive portion, comprising vitamins in aqueous solution; iii) subjecting the bulk medium portion to a high temperature short time treatment (HTST); iv) passing the first additive portion through a virus retentive ultrafilter, wherein or the virus retentive ultrafilter has a molecular weight (Mw) cut-off value below 100 kDa; and v) after steps iii) and iv), mixing the bulk medium portion with the first additive portion to obtain a cell culture medium cleared from viruses. 2. The method of claim 1 , wherein step iii) comprises heating the bulk medium portion to a temperature of about 85-110° C., maintaining said temperature for about 1 s to about 10 min, and cooling the bulk medium portion to <40° C. 3. The method of claim 2 , wherein in step iii) the rate of heating is at least 5° C. per s. 4. The method of claim 2 , wherein in step iii) the rate of cooling is at least 5° C. per s. 5. The method of claim 2 , wherein the heating is performed in a flow-through heater. 6. The method of claim 5 , wherein the flow-through heater is an inductive heater. 7. The method of claim 2 , wherein the cooling is performed in a flow-through cooler. 8. The method of claim 1 , wherein the first additive portion comprises thiamine and/or pantothenic acid. 9. The method of claim 1 , wherein the bulk medium portion is passed through a sterilization-grade filter after step iii) and before step v). 10. The method of claim 1 , wherein after step v), the cell culture medium is passed through a sterilization-grade filter. 11. The method of claim 1 , further comprising the steps of: providing a second additive portion, comprising one or more proteinaceous components; subjecting the second additive portion to gamma or electron beam radiation; and mixing the irradiated second additive portion with the bulk medium portion and the first additive portion to obtain a cell culture medium. 12. The method of claim 11 , wherein the proteinaceous components comprise serum. 13. The method of claim 11 , wherein the proteinaceous components comprise a protein hydrolysate. 14. A method of cultivating cells, comprising the steps as set forth in claim 1 and further comprising the steps of: transferring the cell culture medium cleared from viruses to a bioreactor; transferring cells to the bioreactor; and cultivating the cells in the cell culture medium in the bioreactor. 15. The method of claim 14 , wherein the cells are animal cells. 16. The method of claim 14 , wherein the cells are microbial cells. 17. A method for virus clearance of a cell culture medium, comprising the steps of: i) providing an amino acid portion, comprising amino acids, and a sugar portion, comprising glucose; ii) providing a first additive portion, comprising vitamins in aqueous solution; iii) subjecting the amino acid and sugar portions to a high temperature short time treatment (HTST); iv) passing the first additive portion through a virus retentive ultrafilter, wherein the virus retentive ultrafilter has a molecular weight (Mw) cut-off value below 100 kDa; and v) after steps iii) and iv), mixing the amino acid and sugar portions with the first additive portion to obtain a cell culture medium cleared from viruses. 18. The method of claim 17 , wherein step iii) comprises separately heating the amino acid and sugar portions to a temperature of about 85-110° C., maintaining said temperature for about 1 s to about 10 min, and cooling the amino acid and sugar portions to <40° C. 19. The method of claim 17 , wherein the first additive portion comprises thiamine and/or pantothenic acid. 20. The method of claim 18 , wherein the heating is performed in a flow-through heater and the cooling is performed in a flow-through cooler.

Assignees

Inventors

Classifications

  • Particle radiation, e.g. electron-beam, alpha or beta radiation · CPC title

  • Gamma radiation · CPC title

  • Heat (radiation A61L2/08) · CPC title

  • A61L2/022Primary

    Filtration · CPC title

  • Living organisms or biological materials · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11052165B2 cover?
The invention discloses a method for virus clearance of a cell culture medium, comprising the steps of: i) providing a bulk medium portion, comprising amino acids and glucose, and a first additive portion, comprising vitamins in aqueous solution; ii) subjecting the bulk medium portion to a high temperature short time treatment (HTST); iii) passing the first additive portion through a virus rete…
Who is the assignee on this patent?
Global Life Sciences Solutions Usa Llc
What technology area does this patent fall under?
Primary CPC classification A61L2/022. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).